Archives20242023202220212020201920182017201620152014201320122011 June 11, 2020ImmuPharma PLC (“ImmuPharma” or the “Company”) Director/PDMR Shareholding Read More June 11, 2020Strategic investments from two specialist US healthcare investors for continued development of ImmuPharma’s therapeutic pipeline Read More June 05, 2020Notification of Change of Registered Office Address Read More June 02, 2020Notification of Change of AGM Venue Read More May 21, 2020Notice of AGM and posting of Report & Accounts Read More May 18, 2020TR1 – Notification of major interest in shares by Lanstead Capital Read More May 14, 2020ImmuPharma’s efforts in the fight against Covid-19 with Lupuzor™ and Ureka Read More April 30, 2020Audited Report & Accounts published on website Read More April 30, 2020FINAL RESULTS For the 12 months ended 31 December 2019 Read More April 06, 2020ImmuPharma to present live on ‘Investor Meet Company’ platform Tuesday 7 April 2020 | 10.30am (BST) Read More April 03, 2020TR1 – Notification of major interest in shares by Lanstead Capital – 3 April 2020 Read More April 03, 2020TR1 – Notification of major interest in shares from Robert Zimmer – 2 April 2020 Read More 1234
June 11, 2020Strategic investments from two specialist US healthcare investors for continued development of ImmuPharma’s therapeutic pipeline Read More
April 06, 2020ImmuPharma to present live on ‘Investor Meet Company’ platform Tuesday 7 April 2020 | 10.30am (BST) Read More
April 03, 2020TR1 – Notification of major interest in shares by Lanstead Capital – 3 April 2020 Read More
April 03, 2020TR1 – Notification of major interest in shares from Robert Zimmer – 2 April 2020 Read More
